Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuuvera Inc. V.MIAP

"Nuuvera Inc is a Canadian cannabis company. It is focussed on low-cost cultivation, product development, commercial production and global distribution of cannabis, cannabis oils, cannabinoids and cannabis derivative products in legalized markets. Through its subsidiaries, Nuuvera holds a dealer license under the Narcotic control regulations and the office of controlled substances."


TSXV:MIAP - Post by User

<< Previous
Bullboard Posts
Next >>
Post by MartialArtson Mar 03, 2018 7:30pm
125 Views
Post# 27657070

Why would they not buy the facility?

Why would they not buy the facility?
This is odd isn't it?  Why would they defer the purchase of the facilities as a 60 day option?

FORM 51
-
102F3
MATERIAL CHANGE REPORT
Item 1
Name and Address of Company:
Nuuvera Inc. (“
Nuuvera
” or the “
Company
”)
135 Devon Road, Unit 11
Brampton, Ontario L6T 5A4
Item 2
Date of Material Change:
February 21, 2018 and February 28, 2018.
Item 3
News
Release:
News releases with respect to the material change referenced in this report were
disseminated on February 22, 2018 and March 1, 2018 by Nuuvera via CNW and
copies were subsequently filed on the System for Electronic Document Analysis and
Retrieva
l (SEDAR) website at www.sedar.com.
Item 4
Summary of Material Change:
On February 21, 2018, Nuuvera entered into a definitive share purchase agreement (the
Agreement
”) to acquire, through its subsidiaries, the remaining 49% minority interest
of ARA
-
Av
anti Rx Analytics Inc. (“
Avanti
”), a subsidiary of the Company, from a
single minority shareholder (the “
Acquisition
”).
On February 28, 2018, Nuuvera completed the Acquisition.
Item 5
Full Description of Material Change:
On February 21, 2018, Nuuvera e
ntered into the Agreement to acquire, through its
subsidiaries, the remaining 49% minority interest of Avanti, a subsidiary of the
Company, from a single minority shareholder for a purchase price of $35 million.
On February 28, 2018, Nuuvera completed the
Acquisition.
As part of the Acquisition, Avanti has been granted an option, exercisable for 60 days
following the closing of the Acquisition, to purchase Avanti’s facility at 135 Devon
Road, Brampton, Ontario for $8 million
Item 6
Reliance on subsection
7.1(2) of National Instrument 51
-
102:
Not applicable.
-
2
-
Item 7
-
Omitted Information:
Not applicable.
Item 8
Executive Officer:
The following is the name and telephone number of an executive officer of Nuuvera
who is knowledgeable about the material chang
e and this report:
Contact:
Jordan Greenberg, Chief Financial Officer
Phone No:
416
-
548
-
5998
Item 9
Date of Report:
March 1, 2018
<< Previous
Bullboard Posts
Next >>